Objectives Financial toxicity is recognized as an important adverse effect of cancer treatment
that may decrease patients' health-related quality of life (HRQOL). We aim to perform a …

Objectives: To describe financial toxicity (FT) in patients with resected lung cancer and
identify risk factors in this population. Background: FT describes the financial burden …

Purpose Comprehensive cancer-related financial toxicity (FT) measures as a
multidimensional construct are lacking. The aims of this systematic review were to (1) …

Introduction Economic hardship (EH) can negatively influence cancer outcomes. Little is
known about the factors that are associated with higher levels of EH among patients with …

In China, older cancer survivors may show heterogeneity in financial toxicity (FT). We aimed
to identify FT profiles among older Chinese cancer survivors and examine the association …

Purpose Patients with multiple myeloma and their caregivers are financially burdened, and
their quality of life is significantly affected by treatment costs and care expenses. The aim of …

Purpose This study aims to investigate the factors that influence financial toxicity and its
effects on both quality of life and psychological distress in Turkish cancer patients. Methods …

Purpose Financial toxicity has emerged as a prevalent psychosocial problem in cancer
patients, but data on non-Hodgkin lymphoma patients receiving chemotherapy remain …

Introduction Lung cancer has the second-ranked morbidity rate and the first-ranked mortality
rate worldwide. With the progression of the cancer condition and the advancement of new …

Background It is unknown whether financial well‐being mediates the impact of
multimorbidity on the health‐related quality of life (HRQoL) of cancer patients. Methods …